About this trial
this procedure is to remove inflammatory mediators, reduce friction, stimulate the production of new synovial fluid, eliminate suction-cup effect.
The purpose of this study was to evaluate the hypothesis that TMJ arthrocentesis with injection of autologous micro fragmented adipose tissue leads to better clinical outcomes in terms of reducing pain and improving function compared with arthrocentesis and injection of platelets rich plasma (prp)in patients with TMJ internal derangement and osteoarthritis.
Preliminary results of this clinical trial show that the injection of micro fragmented adipose tissue can significantly improve outcomes of pain and function compared with the standard treatment and encourage to pursue research on this topic.
Further studies with a longer follow-up time are needed to evaluate the clinical stability of the achieved improvement in pain and function.
For this reason, this protocol has been designed with the aim to investigate whether injection in the TMJ of micro fragmented fat tissue can achieve the same improvements of pain and function, compare this technique with prp injection.
Eligibility criteria
Qualifiers
Patients should have one or more signs and symptoms of these
Disc displacement assessed by clinical examination and MRI
Symptoms: Patients who report typical symptoms of TMJ dysfunction, such as pain, discomfort, or clicking sounds in the joint, especially when opening or closing the mouth.
Mouth Opening: Limited range of motion or difficulty with full mouth opening .
Disqualifiers
Previously diagnosed hematological and neurological conditions;
Previous malignant head and neck neoplasms;
Contraindication to fat harvesting.
Uncooperative patients.
Trial design
Treatments tested in this trial
- microfragmented adipose tissue
- platelet-rich plasma